Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer
Status:
Unknown status
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study is to estimate the pathologic complete response rate of cetuximab, irinotecan, and
capecitabine concurrent with radiotherapy given preoperatively in patients with resectable
rectal cancer.